Hajibandeh Shahin, Hajibandeh Shahab, Romman Saleh, Parente Alessandro, Laing Richard W, Satyadas Thomas, Subar Daren, Aroori Somaiah, Bhatt Anand, Durkin Damien, Athwal Tejinderjit S, Roberts Keith J
Department of Hepatobiliary and Pancreatic Surgery, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent ST4 6QG, UK.
Department of Hepatobiliary and Pancreatic Surgery, University Hospital of Wales, Cardiff CF14 4XW, UK.
Biomedicines. 2023 Jul 13;11(7):1983. doi: 10.3390/biomedicines11071983.
To evaluate the ability of the c-reactive protein-to-albumin ratio (CAR) in predicting outcomes in patients undergoing pancreatic cancer resection.
A systematic search of electronic information sources and bibliographic reference lists was conducted. Survival outcomes and perioperative morbidity were the evaluated outcome parameters.
Eight studies reporting a total of 1056 patients undergoing pancreatic cancer resection were identified. The median cut-off value for CAR was 0.05 (range 0.0003-0.54). Using multivariate analysis, all studies demonstrated that a higher CAR value was an independent and significant predictor of poor overall survival in patients undergoing pancreatic cancer resection. The estimated hazard ratio (HR) ranged from 1.4 to 3.6. Although there was a positive correlation between the reported cut-off values for CAR and HRs for overall survival, it was weak and non-significant (r = 0.36, = 6, = 0.480). There was significant between-study heterogeneity.
Preoperative CAR value seems to be an important prognostic score in predicting survival outcomes in patients undergoing pancreatic cancer resection. However, the current evidence does not allow the determination of an optimal cut-off value for CAR, considering the heterogeneous reporting of cut-off values by the available studies and the lack of knowledge of their sensitivity and specificity. Future research is required.
评估C反应蛋白与白蛋白比值(CAR)预测胰腺癌切除患者预后的能力。
对电子信息源和参考文献列表进行系统检索。生存结局和围手术期发病率为评估的结局参数。
共纳入8项研究,涉及1056例行胰腺癌切除术的患者。CAR的中位数临界值为0.05(范围0.0003 - 0.54)。多因素分析显示,所有研究均表明较高的CAR值是胰腺癌切除患者总体生存不良的独立且显著预测因素。估计风险比(HR)范围为1.4至3.6。虽然报告的CAR临界值与总体生存的HR之间存在正相关,但相关性较弱且无统计学意义(r = 0.36,自由度 = 6,P = 0.480)。研究间存在显著异质性。
术前CAR值似乎是预测胰腺癌切除患者生存结局的重要预后指标。然而,鉴于现有研究对临界值的报告存在异质性且对其敏感性和特异性缺乏了解,目前的证据尚无法确定CAR的最佳临界值。需要进一步的研究。